| Website | nextbio.com |
| Employees |
| Total | $8.1M |
| Series A, 2005 | $1.1M |
| Series B, 6/07 Newbury Ventures | $7M |
NextBio is a privately owned interactive life-science search engine company based in California, USA. Nextbio was co-founded by Saeid Akhtari, Ilya Kupershmidt and Mostafa Ronaghi in 2004.
The search engine searches through and correlates complex experiments, literature and clinical data to aid researchers in making new discoveries. It provides an interface for researchers to formulate and test new hypotheses across vast collections of experimental data. The NextBio platform enables biologists, clinicians and biomedical researchers to examine a gene, protein, compound or disease of interest in a global, biological, or clinical context.
The enterprise version of the NextBio search engine is being used in life science R&D and drug development by researchers and clinicians at Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Celgene, Genzyme, Eli Lilly and Company, and Regeneron Pharmaceuticals. All imported data within an enterprise is cross-correlated to previously uploaded internal data and to the public data. Scientists are using NextBio to improve our ability to mine and identify relevant prognostic (survival) and predictive (drug efficacy) molecular signatures which are significant in their research.
NextBio was a receiver of the Frost & Sullivan North American Life Sciences Customer Value Enhancement Award in 2008.
